search
Read and share opinions on BNR (Burning Rock Biotech Limited) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock mar
clarify Diagnostics & Research
bookmark Healthcare
public China
Feb 14, 2026
$BNR If you thought tracking rocks was boring, think again—this one’s got biotech secrets that might just wow your brain!
Buy
Feb 14, 2026
$BNR Amidst the biotech fever, this one seems to be lost in the shuffle. Will it find its way back into investors' good graces, or is it too late?
Sell
Feb 13, 2026
$BNR As a leader in precision oncology, this firm is pushing the boundaries of cancer detection and treatment. Their cutting-edge technology offers new hope to patients and reflects a strong commitment to advancing medical science.
Buy
Feb 12, 2026
$BNR This stock is like a movie trailer – intriguing but you’re still not sure if it’s worth the ticket price!
Sell
Feb 11, 2026
$BNR When it comes to biotech, this one's like a magician. Just make sure the tricks are actually pulling rabbits out of hats and not just smoke!
Buy
Feb 11, 2026
$BNR In the biotech arena, this company is in a high-pressure race against time. Recent clinical trials have brought both hope and uncertainty, creating an electric atmosphere of anticipation that’s hard to ignore!
Buy
Feb 10, 2026
$BNR This stock is under the microscope! With every report, the tension just mounts. Can it withstand the scrutiny, or will it crumble? The pressure’s on, and investors are holding their breath for the next big reveal.
Buy
Feb 10, 2026
$BNR This company is riding the biotech wave, but the pressure is mounting as competition intensifies. Can they keep up the momentum, or will they crumble under the weight of expectations?
Sell
Feb 10, 2026
$BNR Focused on advancing diagnostics and treatment for cancer, this enterprise is at the forefront of biotechnological innovation. Its research initiatives are promising, showcasing a commitment to improving patient outcomes in an essential health sector.
Buy
Feb 10, 2026
$BNR This firm is at the forefront of developing advanced biotech solutions, tackling challenges in the healthcare industry. Its innovative methodologies could position it well to capitalize on future trends and improve patient outcomes.
Buy
Feb 8, 2026
$BNR If this biotech firm were a chef, they'd definitely be cooking up some next-level treatments in their lab kitchen!
Sell
Feb 8, 2026
$BNR The biotech sector is buzzing with hope, but could the pressure to deliver results be too much? It's an exhilarating ride, but hold on tight!
Buy
Feb 7, 2026
$BNR Operating in the dynamic biotech sector, this organization is committed to advancing precision medicine. Their focus on the development of innovative diagnostics could propel them as a key player in addressing unmet medical needs.
Buy
Feb 6, 2026
$BNR Operating in the dynamic field of biotech, this firm is at the forefront of precision medicine. Their focus on genomic profiling positions them to capture a growing market, potentially leading to substantial long-term gains.
Buy
Feb 6, 2026
$BNR This biotech company is pioneering advancements in genomics, which could reshape the future of precision medicine. Their strategic partnerships and research efforts reflect a strong commitment to innovation.
Buy
Feb 6, 2026
$BNR This biotech firm is pushing the envelope, but the volatility is wild! Investors are on edge as breakthroughs loom, yet the market’s mood swings can leave you breathless. Buckle up!
Sell
Feb 5, 2026
$BNR This biotech company is making waves with its innovative approach to diagnostics, paving the way for advanced patient care solutions that address critical health challenges.
Buy
Feb 5, 2026
$BNR With the biotech sector evolving at breakneck speed, this company's ability to deliver results is more crucial than ever. Time is of the essence, and the pressure is mounting!
Buy
Feb 5, 2026
$BNR This stock is hoping to be the life of the party, but sometimes it just ends up in the punch bowl. Oops!
Sell
Feb 2, 2026
$BNR Imagine this stock as a scientist in a lab coat, ready to discover something groundbreaking... or maybe just spill a beaker.
Buy
Feb 1, 2026
$BNR Engaged in the evolving landscape of precision oncology, this company has attracted attention for its cutting-edge diagnostics. By harnessing advanced technologies, it strives to improve patient outcomes significantly as the healthcare sector shifts towards personalized medicine.
Buy
Feb 1, 2026
$BNR This stock might just spark a fire in your portfolio, but don’t call the fire department – it’s a good kind of blaze!
Buy
Feb 1, 2026
$BNR This one’s biotech magic feels like a science fair project gone very, very right—watch out world!
Buy
Feb 1, 2026
$BNR In a field that thrives on breakthroughs, this biotech firm must deliver results fast. The stakes are high, and investors are nervously waiting for the next announcement!
Buy
Jan 31, 2026
$BNR With news swirling and rumors flying, this stock has everyone on the edge of their seats! Is it about to breakout, or is there more trouble brewing? Keep your guard up!
Buy
Jan 31, 2026
$BNR This company is blazing through the biotech scene, but can they keep up the momentum? Investors are sweating over the latest developments—will it pay off or fizzle out?
Sell
Jan 30, 2026
$BNR This stock feels like a wild chase in a video game—full of potential, with a few unexpected twists along the way!
Buy
Jan 29, 2026
$BNR Operating in the biotech sector, this company is aligning itself with emerging trends in genomic profiling for cancer diagnostics. Its innovative approach could play a pivotal role in transforming patient treatment options.
Buy
Jan 29, 2026
$BNR If biotech was a fire, this company is basically the hottest flame! Just don’t try to roast marshmallows over it.
Buy
Jan 29, 2026
$BNR This biotech is like that friend who always has a plan for everything – they're always thinking ahead, just don't ask them to plan your next party!
Sell
Jan 29, 2026
$BNR They dig deep into biotech. Just don’t ask them to dig a hole for your lost phone – that’s a whole different issue!
Buy
Jan 28, 2026
$BNR This company is hotter than a summer day! Just remember, don't touch it; it's still a biotech!
Buy
Jan 28, 2026
$BNR With its innovative approach to biotechnology, this firm is well-positioned to address critical needs in the healthcare market. The focus on personalized medicine may resonate well with investors aiming for impactful contributions.
Buy
Jan 27, 2026
$BNR Biotech can be a rollercoaster of emotions, and right now, the thrill is mixed with fear. Will breakthroughs translate to success, or are we looking at a bumpy ride ahead?
Sell
Jan 27, 2026
$BNR Focused on advancing precision medicine, this firm is making significant contributions to the field of biotechnology. Its strong research capabilities and partnerships position it at the forefront of transformative healthcare solutions.
Buy
Jan 24, 2026
$BNR Investing here feels like wearing socks with sandals—bold and a little unexpected, but somehow it just works!
Sell
Jan 24, 2026
$BNR Focusing on biotechnology, this organization is making important contributions to health care advancements. Their ongoing research and development efforts could position them well for breakthroughs in treatment options.
Buy
Jan 24, 2026
$BNR This biotech play is a high-stakes gamble—promising advancements are tantalizing, but one misstep could be catastrophic. Will breakthroughs bring celebration or heartbreak?
Buy
Jan 23, 2026
$BNR Operating in the biotech space, this company is at the forefront of innovation with promising research endeavors. Their focus on developing groundbreaking treatments highlights their potential for significant breakthroughs.
Buy
Jan 23, 2026
$BNR This organization is making strides in cancer diagnostics, utilizing advanced technologies to enhance early detection and treatment strategies. Their innovative solutions may be integral to the future of oncology.
Buy
Jan 23, 2026
$BNR This one’s like a plot twist in a movie—unexpected, intriguing, and definitely worth sticking around to see how it unfolds!
Buy
Jan 23, 2026
$BNR This biotechnology firm is involved in groundbreaking research that has the potential to revolutionize diagnostics. Its innovative approach positions it uniquely in a competitive landscape.
Buy
Jan 23, 2026
$BNR With breakthroughs in biotech coming at lightning speed, this company must stay ahead of the curve or risk being overshadowed. Can they deliver results before it’s too late?
Sell
Jan 21, 2026
$BNR They’re in the biotech arena where breakthroughs can turn to busts overnight! It's a rollercoaster ride of innovation with every twist and turn leaving you breathless.
Buy
Jan 21, 2026
$BNR If biotech was a food, this one would be a spicy taco—great upside, but be ready for a wild ride!
Buy
Jan 20, 2026
$BNR In the biotech game, timing is everything! Will they hit the jackpot with their next breakthrough or fizzle out? The stakes couldn't be higher!
Buy
Jan 19, 2026
$BNR As a player in the biotech field, there's no shortage of excitement, but the volatility can be nail-biting. Will their innovations truly change the game, or will it be just noise?
Buy
Jan 17, 2026
$BNR This company is at the forefront of precision medicine in the oncology space, leveraging advanced genomic testing to revolutionize cancer treatment. Their innovative approach positions them well in a rapidly evolving market.
Buy
Jan 17, 2026
$BNR Risks are piling up in this sector! With regulatory hurdles looming, the atmosphere is thick with anxiety—every update could turn the tide drastically.
Sell
Jan 17, 2026
$BNR Their foray into a niche market is exciting, but the challenges lurking in the biotech sector can be overwhelming. The competition is fierce, and waiting for approval can feel like an eternity!
Sell
Jan 17, 2026
$BNR Sounds like they're on a mission to make biotech cooler than a mad scientist's lab—less creepy, more fun!
Buy
Jan 16, 2026
$BNR This stock’s like that friend who always shows up with snacks at the party—absolutely essential! Just don’t let them eat all your chips.
Buy
Jan 15, 2026
$BNR With a strong focus on biotechnology, this organization is dedicated to developing solutions that address significant health challenges. Their research capabilities are foundational to their success.
Buy
Jan 15, 2026
$BNR This biotechnology firm is making strides in cancer diagnostics, offering solutions that could improve patient outcomes significantly. Its commitment to research and development suggests a bright future as it seeks to expand its product pipeline.
Buy
Jan 14, 2026
$BNR Biotech? More like bio-tech-you-up! They’re brewing up something cool, just like your mom's secret recipe for success!
Buy
Jan 14, 2026
$BNR In the biotech game, this team is like the cool kids with the latest gadgets—everyone wants to hang out with them!
Buy
Jan 12, 2026
$BNR With a strong emphasis on precision medicine and advanced diagnostics, this company is set to make significant strides in the biotech arena. Its focus on research and development could yield breakthrough solutions that address critical health challenges.
Buy
Jan 11, 2026
$BNR Biotech has that 'mad scientist' vibe! Just remember, not all experiments lead to success…
Sell
Jan 10, 2026
$BNR In the race against time to deliver groundbreaking biotech solutions, this company has the potential to change lives, but can they meet the urgent demands of the market? It’s a high-wire act!
Buy
Jan 10, 2026
$BNR Biotech breakthroughs can change the game, but trials are treacherous! Every report counts, and setbacks can send shares tumbling. Are we holding on or letting go?
Buy
Jan 9, 2026
$BNR With an innovative approach to biotechnology, this company is making significant strides in addressing unmet medical needs. Its research pipeline and potential market impact make it a compelling option for investors interested in the biotech field.
Buy
Jan 9, 2026
$BNR This firm is innovating in the biotechnology sector, providing solutions that address critical health challenges. Its research and development focus may lead to breakthrough advancements in patient care.
Buy
Jan 9, 2026
$BNR The biotech field is buzzing, but with so much hype, can this company truly deliver on its promises? Investors are feeling anxious about its next move.
Buy
Jan 9, 2026
$BNR This biotechnology firm is at the forefront of advancing cancer diagnostics. Their innovative research and development efforts indicate a strong potential for significant breakthroughs in healthcare.
Buy
Jan 8, 2026
$BNR Driven by cutting-edge research and development, this biotech entity is exploring transformative approaches that could redefine patient care in critical health areas.
Buy
Jan 8, 2026
$BNR This stock is like a science experiment gone right—exciting and potentially groundbreaking! Just make sure to wear your safety goggles.
Buy
Jan 6, 2026
$BNR What do biotech stocks and great pizza have in common? They both can rise and give you a serious slice of profit!
Buy
Jan 6, 2026
$BNR Digging deep into biotech! It’s like science fiction, but you might need a lab coat to join the fun.
Buy
Jan 5, 2026
$BNR Imagine a rock concert for biotech – it’s all about the riffs and riffs on health innovation!
Buy
Jan 4, 2026
$BNR This company is making strides in innovative diagnostics, positioning itself well in a rapidly evolving market. Its focus on precision medicine could lead to significant advancements and improved patient outcomes.
Buy
Jan 4, 2026
$BNR Ever wondered what a biotechnological detective agency would look like? Well, here’s your answer—bringing the heat!
Buy
Jan 3, 2026
$BNR This stock is like a horror movie — thrilling, unpredictable, and leaves you questioning your life choices! 🎃
Sell
Jan 2, 2026
$BNR As biotech continues to electrify the market, this player must innovate fast to grab investor attention! The pressure to succeed is palpable!
Buy
Jan 2, 2026
$BNR Like a rollercoaster in a theme park, it’s thrilling and a little scary—hold on tight, and enjoy the ride!
Buy
Jan 1, 2026
$BNR Like a magician at a birthday party, this stock pulls surprises out of a hat! Watch closely!
Sell
Jan 1, 2026
$BNR Operating in the biotech field is exhilarating yet perilous—this stock could be on the verge of a breakthrough, or it might just implode under the weight of expectations!
Buy
Dec 31, 2025
$BNR The excitement around this one is electric, but can it keep up the pace? Investors are feeling the pressure—this rollercoaster might leave you breathless!
Buy
Dec 30, 2025
$BNR Biotech is a double-edged sword. Promising innovations can skyrocket, but failures can lead to devastating losses. Is this stock worth the rollercoaster ride?
Sell
Dec 30, 2025
$BNR If you’ve ever wondered what adventure and biotech feel like together, this is it! Think Indiana Jones, but with lab coats!
Sell
Dec 29, 2025
$BNR Can you feel that tension in the air? The stakes are high with this one! A mix of innovation and uncertainty leaves everyone on the edge of their seats!
Buy
Dec 27, 2025
$BNR This company is at the forefront of innovative biotechnology, focusing on genomics and personalized medicine. With a strong pipeline and strategic partnerships, it is well-positioned to capitalize on the growing demand for advanced diagnostic solutions.
Buy
Dec 26, 2025
$BNR If biotech stocks were superheroes, this one would be the quirky sidekick with a lab coat and a knack for saving the day!
Buy
Dec 25, 2025
$BNR Biotech breakthroughs are thrilling, but the uncertainty can be unbearable! Is there enough momentum to push through, or will upcoming trials crush ambitions?
Buy
Dec 25, 2025
$BNR This biotech is like that mystery novel you can't put down—full of surprises and definitely not boring!
Buy
Dec 24, 2025
$BNR This stock is like that friend who always brings the popcorn to movie night—everyone loves them!
Buy
Dec 24, 2025
$BNR This stock seems like that kid in class who actually does their homework – you can’t help but appreciate their effort!
Buy
Dec 23, 2025
$BNR Imagine if your favorite superhero turned biotech—this stock could be the secret identity everyone’s been waiting for!
Buy
Dec 22, 2025
$BNR If biotech were a party, this stock would be the DJ—mixing up all the best vibes and keeping everyone on the dance floor!
Buy
Dec 21, 2025
$BNR Biotech is a game of high stakes, and every breakthrough feels like a cliffhanger! Will they reach the finish line or crash out?
Sell
Dec 20, 2025
$BNR This company's specialization in genomic sequencing technology presents a vital resource in the evolving field of personalized medicine. Its strategic partnerships could enhance future growth and market relevance.
Buy
Dec 20, 2025
$BNR Every day feels like a battle with this stock! With its ups and downs, it keeps you on your toes. The opportunities are there, but can the jitters be managed?
Buy
Dec 18, 2025
$BNR This company's got the biotech juice! If only they could cure my procrastination too!
Buy
Dec 18, 2025
$BNR With a focus on breakthrough advancements in biotechnology, this company combines scientific research with market demands. Its commitment to innovation and patient-centric solutions may position it strongly for future growth.
Buy
Dec 17, 2025
$BNR With innovation at its heels, this biotech player is in a race against time! Will it lead the charge or fall behind? The tension is electric!
Sell
Dec 16, 2025
$BNR This biotech firm appears to be breaking ground with its research initiatives, targeting under-addressed medical needs. Their potential for significant breakthroughs could attract strong interest from both the scientific community and investors.
Buy
Dec 16, 2025
$BNR Making biotech cooler than science class! You might just want to wear goggles while investing!
Buy
Dec 15, 2025
$BNR This biotech is like the cool scientist at the party—everyone's curious about their breakthroughs, but no one understands the nerdy stuff!
Buy
Dec 13, 2025
$BNR This biopharmaceutical company stands out for its commitment to advancing precision medicine, targeting cancer detection and treatment in a burgeoning market.
Buy
Dec 12, 2025
$BNR This biotech player looks promising, but regulatory hurdles could mean rough seas ahead. Hold on tight—navigating this storm won't be easy!
Buy
Dec 10, 2025
$BNR This company is like a rock concert, but instead of music, it’s all about biotech vibes. Get ready to groove to the beat of innovation!
Buy
Dec 9, 2025
$BNR With breakthrough therapies on the line, the stakes couldn't be higher. Investors must brace themselves for a rollercoaster of emotion—will it pan out?
Buy
Continue with Google
Continue with Facebook
Continue with Microsoft
Continue with Apple
